TSS
NVO

Two Sigma Securities’s Novo Nordisk NVO Stock Holding History

Two Sigma Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,500
Closed -$5.66M – 2725
2024
Q3 		$5.66M Sell
47,500
-63,600
-57% -$8.48M 0.1% 254
2024
Q2 		$15.9M Sell
111,100
-6,900
-6% -$914K 0.19% 110
2024
Q1 		$15.2M Buy
118,000
+55,900
+90% +$6.65M 0.15% 161
2023
Q4 		$6.42M Buy
62,100
+21,700
+54% +$2.15M 0.06% 301
2023
Q3 		$3.67M Buy
+40,400
New +$3.56M 0.04% 452
2022
Q4 		– Sell
-9,800
Closed -$488K – 3058
2022
Q3 		$488K Buy
+9,800
New +$525K 0.01% 1126
2022
Q2 		– Sell
-7,600
Closed -$422K – 2664
2022
Q1 		$422K Buy
+7,600
New +$390K 0.01% 1133
2019
Q4 		– Sell
-13,600
Closed -$352K – 2554
2019
Q3 		$352K Buy
+13,600
New +$344K ﹤0.01% 1431
2018
Q4 		– Sell
-9,800
Closed -$231K – 2617
2018
Q3 		$231K Sell
9,800
-40,800
-81% -$996K ﹤0.01% 1991
2018
Q2 		$1.17M Buy
50,600
+31,600
+166% +$751K 0.01% 1242
2018
Q1 		$468K Buy
19,000
+10,400
+121% +$273K ﹤0.01% 1709
2017
Q4 		$231K Buy
+8,600
New +$219K 0.01% 1198

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Securities's NVO Position: Q4 2025 in Review

Two Sigma Securities sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 18,291 shares — an estimated $1.01M sold.

Two Sigma Securities first reported a position in NVO in Q4 2016 and held it in 19 quarters. The position peaked at $15.5M in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Two Sigma Securities reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 18,291 Novo Nordisk shares in Q4 2025, an estimated $1.01M.
  • Two Sigma Securities first reported a position in Novo Nordisk in Q4 2016 and held it in 19 quarters.
  • Two Sigma Securities's Novo Nordisk position peaked at $15.5M in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.